These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 9505973)
1. Cross virus neutralizing antibodies against feline immunodeficiency virus genotypes A, B, C, D and E. Inoshima Y; Miyazawa T; Kohmoto M; Ikeda Y; Sato E; Hohdatsu T; Mathiason-Dubard C; Hoover EA; Mikami T Arch Virol; 1998; 143(1):157-62. PubMed ID: 9505973 [TBL] [Abstract][Full Text] [Related]
2. Virus neutralizing antibody titer to feline immunodeficiency virus isolates of subtypes A, B and D in experimentally or naturally infected cats. Hohdatsu T; Fujimori S; Maeki M; Suma N; Motokawa K; Okada S; Koyama H J Vet Med Sci; 1997 May; 59(5):377-81. PubMed ID: 9192359 [TBL] [Abstract][Full Text] [Related]
3. Mutations in feline immunodeficiency (FIV) virus envelope gene V3-V5 regions in FIV-infected cats. Motokawa K; Hohdatsu T; Imori A; Arai S; Koyama H Vet Microbiol; 2005 Mar; 106(1-2):33-40. PubMed ID: 15737471 [TBL] [Abstract][Full Text] [Related]
5. Virus neutralization reveals antigenic variation among feline immunodeficiency virus isolates. Osborne R; Rigby M; Siebelink K; Neil JC; Jarrett O J Gen Virol; 1994 Dec; 75 ( Pt 12)():3641-5. PubMed ID: 7996159 [TBL] [Abstract][Full Text] [Related]
6. Autologous and heterologous neutralization analyses of primary feline immunodeficiency virus isolates. Del Mauro D; Matteucci D; Giannecchini S; Maggi F; Pistello M; Bendinelli M J Virol; 1998 Mar; 72(3):2199-207. PubMed ID: 9499077 [TBL] [Abstract][Full Text] [Related]
7. A neutralizing antibody-inducing peptide of the V3 domain of feline immunodeficiency virus envelope glycoprotein does not induce protective immunity. Lombardi S; Garzelli C; Pistello M; Massi C; Matteucci D; Baldinotti F; Cammarota G; da Prato L; Bandecchi P; Tozzini F J Virol; 1994 Dec; 68(12):8374-9. PubMed ID: 7966629 [TBL] [Abstract][Full Text] [Related]
8. Efficacy evaluation of prime-boost protocol: canarypoxvirus-based feline immunodeficiency virus (FIV) vaccine and inactivated FIV-infected cell vaccine against heterologous FIV challenge in cats. Tellier MC; Pu R; Pollock D; Vitsky A; Tartaglia J; Paoletti E; Yamamoto JK AIDS; 1998 Jan; 12(1):11-8. PubMed ID: 9456250 [TBL] [Abstract][Full Text] [Related]
9. Molecular subtyping of feline immunodeficiency virus from cats in Melbourne. Iwata D; Holloway SA Aust Vet J; 2008 Oct; 86(10):385-9. PubMed ID: 18826508 [TBL] [Abstract][Full Text] [Related]
10. Simple in vitro methods for titrating feline immunodeficiency virus (FIV) and FIV neutralizing antibodies. Tozzini F; Matteucci D; Bandecchi P; Baldinotti F; Poli A; Pistello M; Siebelink KH; Ceccherini-Nelli L; Bendinelli M J Virol Methods; 1992 Jun; 37(3):241-52. PubMed ID: 1321834 [TBL] [Abstract][Full Text] [Related]
11. Phylogenetic analysis of feline immunodeficiency virus strains from naturally infected cats in Belgium and The Netherlands. Roukaerts ID; Theuns S; Taffin ER; Daminet S; Nauwynck HJ Virus Res; 2015 Jan; 196():30-6. PubMed ID: 25449575 [TBL] [Abstract][Full Text] [Related]
12. Characterization of two monoclonal antibodies against feline immunodeficiency virus gag gene products and their application in an assay to evaluate neutralizing antibody activity. Fevereiro M; Roneker C; Laufs A; Tavares L; de Noronha F J Gen Virol; 1991 Mar; 72 ( Pt 3)():617-22. PubMed ID: 1848596 [TBL] [Abstract][Full Text] [Related]
13. Differentiation of feline immunodeficiency virus vaccination, infection, or vaccination and infection in cats. Levy JK; Crawford PC; Kusuhara H; Motokawa K; Gemma T; Watanabe R; Arai S; Bienzle D; Hohdatsu T J Vet Intern Med; 2008; 22(2):330-4. PubMed ID: 18371028 [TBL] [Abstract][Full Text] [Related]
14. Two different mutations in the envelope protein of feline immunodeficiency virus allow the virus to escape from neutralization by feline serum antibodies. Siebelink KH; Bosch ML; Rimmelzwaan GF; Meloen RH; Osterhaus AD Vet Immunol Immunopathol; 1995 May; 46(1-2):51-9. PubMed ID: 7542412 [TBL] [Abstract][Full Text] [Related]
15. Involvement of gag- and env-specific cytotoxic T lymphocytes in protective immunity to feline immunodeficiency virus. Flynn JN; Beatty JA; Cannon CA; Stephens EB; Hosie MJ; Neil JC; Jarrett O AIDS Res Hum Retroviruses; 1995 Sep; 11(9):1107-13. PubMed ID: 8554908 [TBL] [Abstract][Full Text] [Related]